LEDIFOS inhibits key viral enzymes required for replication, effectively halting the hepatitis C virus lifecycle.
Recommended for:
Chronic HCV (genotypes 1 and 4)
Interferon-free treatment approach
Compensated cirrhosis
Treatment-naïve and previously treated patients
Chronic Hepatitis C infection
Genotype 1 or 4
With or without cirrhosis
Single or combination therapy
Take one tablet orally once daily at the same time each day, with or without food. Duration of therapy is usually 12 weeks, as directed by a physician.
Contraindications:
Hypersensitivity to ingredients
Co-administration with rifampicin, carbamazepine
Pregnancy and lactation (lack of safety data)
Side Effects:
Headache, fatigue
Nausea, insomnia
GI disturbances
Allergic skin reactions